Cogent Biosciences (COGT) Other Working Capital Changes (2018 - 2020)
Cogent Biosciences (COGT) posted quarterly Other Working Capital Changes of -$312000.0 for Q3 2020, up 31.88% year-over-year from -$236582.8 in Q4 2019, and up 41.02% quarter-over-quarter from -$529000.0 in Q2 2020.
Cogent Biosciences (COGT) Other Working Capital Changes (2018 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has reported Other Working Capital Changes for 3 consecutive years, with -$312000.0 the latest figure, recorded in Q3 2020.
- In Q3 2020, Other Working Capital Changes rose 31.88% year-over-year to -$312000.0; the TTM figure through Dec 2020 stood at -$1.3 million (up 92.09% YoY), while the FY2020 annual figure was -$1.3 million, up 92.09% from the prior year.
- Other Working Capital Changes improved to -$312000.0 in Q3 2020 per COGT's latest filing, from -$529000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.3 million in Q4 2024 and bottomed at -$3.0 million in Q3 2025.
- Historically, Other Working Capital Changes has averaged $443785.7 across 5 years, with a median of $58500.0 in 2023.
- Annual changes were most pronounced in 2019 — Other Working Capital Changes plunged 527.14% — and 2020, when it soared 69.94%.
- Cogent Biosciences' Other Working Capital Changes stood at -$2.1 million in 2018, then slumped by 527.14% to -$13.4 million in 2019, then surged by 97.67% to -$312000.0 in 2020.
- Business Quant data shows COGT's Other Working Capital Changes at -$312000.0 in Q3 2020, -$529000.0 in Q2 2020, and -$474000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -312,000.00 |
| Sep 30, 2020 | -312,000.00 |
| Sep 30, 2020 | -312,000.00 |
| Jun 30, 2020 | -529,000.00 |
| Jun 30, 2020 | -529,000.00 |
| Jun 30, 2020 | -529,000.00 |
| Mar 31, 2020 | -474,000.00 |
| Mar 31, 2020 | -474,000.00 |
| Mar 31, 2020 | -474,000.00 |
| Dec 31, 2019 | -13.40 Mn |
| Dec 31, 2019 | -13.40 Mn |
| Dec 31, 2019 | -13.40 Mn |
| Sep 30, 2019 | -458,000.00 |
| Sep 30, 2019 | -458,000.00 |
| Sep 30, 2019 | -458,000.00 |
| Jun 30, 2019 | -1.76 Mn |
| Jun 30, 2019 | -1.76 Mn |
| Jun 30, 2019 | -1.76 Mn |
| Mar 31, 2019 | -1.01 Mn |
| Mar 31, 2019 | -1.01 Mn |